Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Rhenman & Partners Asset Management AB
Form 13F · Q2 2026

Rhenman & Partners Asset Management AB

CIK 1599882申報日 2026-08-1313F-HR 在 EDGAR 查看原始申報 ↗
$10.6亿
申報組合市值
99
持倉數量
12
Quarters on record
Top 50
持倉數量

Rhenman & Partners Asset Management AB——持倉

共 99 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1UNH Unitedhealth Group Inc93,600+105.7%$3890万3.7%
2CVS Cvs Health Corp279,374−17.0%$2890万2.7%
3AZN Astrazeneca Plc151,500—$2848万2.7%
4MRK Merck & Co Inc213,500—$2743万2.6%
5LLY Eli Lilly & Co22,315−33.8%$2677万2.5%
6ABBV Abbvie Inc96,775+35.2%$2435万2.3%
7ALHC Alignment Healthcare Inc997,083−5.4%$2374万2.2%
8EW Edwards Lifesciences Corp260,000+59.5%$2352万2.2%
9GILD Gilead Sciences Inc178,250+6.3%$2252万2.1%
10JAZZ Jazz Pharmaceuticals Plc87,440+15.2%$2107万2.0%
11BIIB Biogen Inc94,850−13.1%$2049万1.9%
12SYK Stryker Corporation65,000+36.0%$2046万1.9%
13BSX Boston Scientific Corp450,500−27.9%$1923万1.8%
14JNJ Johnson & Johnson72,500—$1841万1.7%
15GH Guardant Health Inc115,000−20.7%$1725万1.6%
16REGN Regeneron Pharmaceuticals27,390−43.1%$1708万1.6%
17GKOS Glaukos Corp119,000+41.7%$1663万1.6%
18BMRN Biomarin Pharmaceutical Inc290,500+40.3%$1662万1.6%
19NRIX Nurix Therapeutics Inc684,250+118.3%$1660万1.6%
20NTRA Natera Inc61,050+18.3%$1657万1.6%
21MIRM Mirum Pharmaceuticals Inc139,205+50.3%$1630万1.5%
22INSM Insmed Inc151,960−4.9%$1620万1.5%
23THC Tenet Healthcare Corp85,200+57.8%$1594万1.5%
24TMO Thermo Fisher Scientific Inc31,580−23.6%$1583万1.5%
25CNC Centene Corp Del244,000—$1566万1.5%
26AXSM Axsome Therapeutics Inc.63,050−1.2%$1543万1.5%
27DHR Danaher Corp Del80,252+344.6%$1529万1.4%
28VRTX Vertex Pharmaceuticals Inc30,685−29.4%$1524万1.4%
29AVR Anteris Technologies Global1.5M+7.0%$1516万1.4%
30NBIX Neurocrine Biosciences Inc85,841−14.9%$1447万1.4%
31PNTG Pennant Group Inc371,471+34.9%$1373万1.3%
32ISRG Intuitive Surgical Inc34,500−6.4%$1372万1.3%
33ELV Elevance Health Inc Formerly34,900+8.0%$1350万1.3%
34LIVN Livanova Plc164,000+5.8%$1349万1.3%
35COR Cencora Inc46,778−10.7%$1324万1.2%
36CRL Charles Riv Labs Intl Inc57,200+120.0%$1297万1.2%
37IDYA Ideaya Biosciences Inc343,800+34.6%$1281万1.2%
38MCK Mckesson Corp16,550−1.8%$1251万1.2%
39SNDX Syndax Pharmaceuticals Inc560,250+47.7%$1225万1.2%
40BTSG Brightspring Health Svcs Inc165,896+231.8%$1157万1.1%
41MDT Medtronic Plc145,000+61.1%$1134万1.1%
42MLYS Mineralys Therapeutics Inc416,371+58.3%$1123万1.1%
43OSCR Oscar Health Inc392,000−40.6%$1118万1.1%
44RPRX Royalty Pharma Plc197,000−15.5%$1105万1.0%
45DXCM Dexcom Inc160,000—$1078万1.0%
46ALGN Align Technology Inc63,000+740.0%$1063万1.0%
47SYRE Spyre Therapeutics Inc119,300—$1059万1.0%
48RLAY Relay Therapeutics Inc566,000+57.2%$1059万1.0%
49ARWR Arrowhead Pharmaceuticals In128,000−11.4%$1043万1.0%
50A Agilent Technologies Inc75,000+200.0%$996万0.9%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。